Related Experiment Video
Updated: Jan 8, 2026

Author Spotlight: Insights into Visual Cortex Research Through Wide-View fMRI Mapping
Published on: December 8, 2023
Lightweight Vision Transformer with transfer learning for interpretable Alzheimer's disease severity assessment
Ruhika Sharma1,2, Vishal Acharya3,4
1Artificial Intelligence for Computational Biology (AICoB) Laboratory, Biotechnology Division, CSIR-Institute of Himalayan Bioresource Technology, Palampur, 176061, Himachal Pradesh, India.
A new deep learning framework, ViTTL, accurately diagnoses Alzheimer's disease (AD) using MRI scans. This lightweight tool offers interpretable results and efficient deployment for improved patient outcomes.
Area of Science:
- Neuroimaging
- Artificial Intelligence
- Medical Diagnostics
Background:
- Alzheimer's disease (AD) diagnosis relies on early detection for effective management.
- Current diagnostic methods can be invasive or lack accessibility.
- Developing reliable, non-invasive tools is crucial for slowing AD progression.
Purpose of the Study:
- To introduce ViTTL, a lightweight deep learning framework for Alzheimer's disease severity assessment using MRI data.
- To evaluate the performance and interpretability of ViTTL.
- To demonstrate the potential for clinical translation and improved patient outcomes.
Main Methods:
- ViTTL integrates Vision Transformers (ViT) with pre-trained convolutional neural networks (CNNs) for feature extraction from 2D MRI slices.
- The ViT-DenseNet201 model combined with an artificial neural network (ANN) classifier was evaluated.
- Interpretability was achieved using LIME and GRAD-CAM methods.
Main Results:
- The ViT-DenseNet201-ANN model achieved 99.89% classification accuracy on the OASIS dataset.
- Interpretability methods consistently highlighted cortical and hippocampal regions associated with AD pathology (Dice score: 0.85 ± 0.03).
- ViTTL demonstrated significant model size reduction (83.0 MB to 6.47 MB) and robust performance on independent datasets.
Conclusions:
- ViTTL provides an accurate, interpretable, and resource-efficient solution for Alzheimer's disease diagnosis.
- The framework's reduced size and strong performance suggest potential for deployment in resource-limited clinical settings.
- ViTTL shows promise for clinical translation, potentially improving early AD detection and patient management.
More Related Videos
09:47Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
Published on: December 15, 2023
12:50Lesion Explorer: A Video-guided, Standardized Protocol for Accurate and Reliable MRI-derived Volumetrics in Alzheimer's Disease and Normal Elderly
Published on: April 14, 2014
Related Concept Videos
Alzheimer's Disease: Treatment
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...